Novartis to Showcase Cardiovascular Data at ESC Congress
Novartis plans to present 10 abstracts on its cardiovascular portfolio at the 2026 European Society of Cardiology (ESC) Congress. Late-breaking Phase 4 VICTORION-CHALLENGE…
Novartis plans to present 10 abstracts on its cardiovascular portfolio at the 2026 European Society of Cardiology (ESC) Congress. Late-breaking Phase 4 VICTORION-CHALLENGE…
Geberit reported first-half 2026 net sales of CHF 1,711 million, an increase of 5.9% when adjusted for currency effects. The company’s operating cashflow…
dsm-firmenich’s Board of Directors proposed Richard Ridinger as its next Chairman. The company said current Chairman Thomas Leysen will retire after his successor…
It is official now, after the initial announcement in April: Wolfgang Wienand becomes CEO of Lonza Group, succeeding Albert M. Baehny.
Tarak Mehta, President of Motion Business at ABB, is leaving to become CEO of another company after a 26-year career at ABB.
Novartis receives positive CHMP opinion for Fabhalta® as first oral monotherapy for PNH in adults.
Givaudan SA's 2024 Annual General Meeting on March 21st saw approval of all Board proposals, a 1.5% dividend increase for the 23rd year,…
Kuehne+Nagel opens a new fulfillment center in Piscataway, New Jersey, serving as a fashion hub for luxury retailers, featuring automation, EV charging stations,…
Lonza acquires Genentech's Vacaville biologics site from Roche for $1.2 billion, expanding large-scale manufacturing capacity in the US, investing $500 million for upgrades.
World Sailing partners with Kuehne+Nagel for three years to handle logistics for sailing events, focusing on sustainability and decarbonization.